Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia

by Hou, H-A, Kuo, Y-Y, Liu, C-Y, Lee, M C, Tang, J-L, Chen, C-Y, Chou, W-C, Huang, C-F, Lee, F-Y, Liu, M-C, Yao, M, Tien, H-F
Published 2011

The UKIRT Hemisphere Survey: definition and J-band data release

by Dye, S., Lawrence, A., Read, M.A., Fan, X., Kerr, T., Varricatt, W., Furnell, K.E., Edge, A.C., Irwin, M., Hambly, N., Lucas, P., Almaini, O., Chambers, K., Green, R., Hewett, P., Liu, M.C., McGreer, I., Best, W., Zhang, Z., Sutorius, E., Froebrich, D., Magnier, E., Hasinger, G., Lederer, S.M., Bold, M., Tedds, J.A.
Published 2018

Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome

by Chen, T-C, Hou, H-A, Chou, W-C, Tang, J-L, Kuo, Y-Y, Chen, C-Y, Tseng, M-H, Huang, C-F, Lai, Y-J, Chiang, Y-C, Lee, F-Y, Liu, M-C, Liu, C-W, Liu, C-Y, Yao, M, Huang, S-Y, Ko, B-S, Hsu, S-C, Wu, S-J, Tsay, W, Chen, Y-C, Tien, H-F
Published 2014

TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution

by Hou, H-A, Chou, W-C, Kuo, Y-Y, Liu, C-Y, Lin, L-I, Tseng, M-H, Chiang, Y-C, Liu, M-C, Liu, C-W, Tang, J-L, Yao, M, Li, C-C, Huang, S-Y, Ko, B-S, Hsu, S-C, Chen, C-Y, Lin, C-T, Wu, S-J, Tsay, W, Chen, Y-C, Tien, H-F
Published 2015

Predicting response and survival in chemotherapy-treated triple-negative breast cancer

by Prat, A, Lluch, A, Albanell, J, Barry, W T, Fan, C, Chacón, J I, Parker, J S, Calvo, L, Plazaola, A, Arcusa, A, Seguí-Palmer, M A, Burgues, O, Ribelles, N, Rodriguez-Lescure, A, Guerrero, A, Ruiz-Borrego, M, Munarriz, B, López, J A, Adamo, B, Cheang, M C U, Li, Y, Hu, Z, Gulley, M L, Vidal, M J, Pitcher, B N, Liu, M C, Citron, M L, Ellis, M J, Mardis, E, Vickery, T, Hudis, C A, Winer, E P, Carey, L A, Caballero, R, Carrasco, E, Martín, M, Perou, C M, Alba, E
Published 2014